preeclampia - Nursing Case Study

Pathophysiology

• Primary mechanism: Abnormal placentation leads to impaired trophoblastic invasion of the uterine spiral arteries, resulting in high-resistance blood flow and reduced placental perfusion. This triggers systemic endothelial dysfunction, a hallmark of preeclampsia.

• Secondary mechanism: Endothelial dysfunction causes increased release of antiangiogenic factors like soluble fms-like tyrosine kinase-1 (sFlt-1) and decreased proangiogenic factors such as placental growth factor (PlGF), exacerbating vascular imbalance and hypertension.

• Key complication: Severe complications arise from widespread endothelial damage and vasoconstriction, including multi-organ injury, such as renal failure, liver dysfunction, cerebral edema, and risk of maternal and fetal morbidity and mortality.

Patient Profile

Demographics:

32-year-old female, nurse

History:

• Key past medical history: Chronic hypertension, Type 2 Diabetes

• Current medications: Labetalol, Metformin, Prenatal vitamins

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Severe headache and visual disturbances

• Key symptoms: Persistent epigastric pain, shortness of breath, swelling in hands and face

• Vital signs: Blood pressure 190/120 mmHg, heart rate 110 bpm, respiratory rate 24 breaths per minute, temperature 37.8°C, oxygen saturation 92% on room air

Section 1

As the clinical team initiates a comprehensive assessment of the patient, they uncover critical findings that suggest a rapid progression of her condition. Upon physical examination, the patient exhibits marked pitting edema in the lower extremities, and her deep tendon reflexes are brisk, indicating heightened neuromuscular irritability. Auscultation reveals bilateral crackles at the lung bases, suggesting fluid overload and possible pulmonary edema, a severe complication of preeclampsia. Laboratory results are alarming, with serum creatinine elevated to 2.3 mg/dL, indicating renal impairment, and liver function tests showing a marked increase in AST and ALT levels, pointing towards hepatic involvement. Urinalysis reveals significant proteinuria at 4 grams per 24 hours, further confirming the diagnosis of severe preeclampsia.

While the team administers intravenous magnesium sulfate to prevent seizures and aims to control her hypertension with a continuous infusion of labetalol, the patient's condition deteriorates. She becomes increasingly disoriented and agitated, indicating potential cerebral involvement. A stat CT scan of the head is ordered to rule out cerebral edema or hemorrhage. Meanwhile, fetal monitoring displays recurrent late decelerations, raising concerns about fetal distress and necessitating a possible expedited delivery plan. These developments demand advanced clinical reasoning as the team considers the risks of continuing the pregnancy against the immediate need for maternal stabilization.

The critical juncture now lies in addressing the possibility of HELLP syndrome, given the liver function abnormalities and thrombocytopenia observed. Platelet count has dropped to 85,000/mm³, and the team must assess the risk of disseminated intravascular coagulation (DIC), given the potential for further coagulation disturbances. This complex scenario requires ongoing interdisciplinary collaboration to reassess priorities, weighing maternal and fetal risks and benefits, and planning for an urgent yet strategic intervention that ensures the best possible outcomes for both mother and child.

Section 2

Despite the efforts to stabilize the patient, new complications arise that heighten the urgency of the situation. The stat CT scan of the head reveals no evidence of cerebral edema or hemorrhage, providing some relief to the team. However, the patient's disorientation and agitation persist, suggesting a possible progression towards eclampsia. Concurrently, fetal monitoring continues to show recurrent late decelerations with minimal variability, indicating worsening fetal distress. The team decides to proceed with an expedited delivery, balancing the need for maternal stabilization with fetal viability.

As preparations for an emergency cesarean section begin, the patient's vital signs indicate further deterioration. Her blood pressure remains dangerously high at 180/110 mmHg despite the labetalol infusion, and her respiratory rate increases to 28 breaths per minute with oxygen saturation dropping to 90%. This points towards worsening pulmonary edema, necessitating immediate intervention to optimize maternal oxygenation. The decision is made to administer furosemide in an attempt to rapidly reduce fluid overload and improve respiratory status.

Additionally, new laboratory results reveal further complications. The patient's platelet count has decreased to 70,000/mm³, and her coagulation profile shows an elevated D-dimer level, raising concerns about the onset of DIC. These findings necessitate an urgent hematology consultation to guide management and mitigate the risk of bleeding during delivery. The clinical team must now exercise advanced critical thinking to navigate these overlapping challenges, prioritize interventions, and coordinate the complex care required to ensure the best possible outcomes for both the mother and the fetus.

Section 3

As the clinical team prepares for the emergency cesarean section, they carefully monitor the patient's response to the administered interventions. Despite the administration of furosemide, the patient's respiratory status shows minimal improvement; her oxygen saturation hovers around 92% with high-flow oxygen, and she continues to exhibit signs of tachypnea. A repeat arterial blood gas analysis reveals a concerning respiratory alkalosis with a pH of 7.48, PaCO2 of 30 mmHg, and PaO2 of 55 mmHg, indicating a persistent oxygenation issue likely exacerbated by pulmonary edema. The team recognizes the need for further respiratory support and prepares for potential intubation to ensure adequate oxygen delivery during surgery.

Concurrently, the patient's hemodynamic status remains precarious. Her blood pressure remains elevated at 175/108 mmHg despite continued antihypertensive therapy, and she begins to exhibit signs of altered mental status, including confusion and intermittent somnolence. The repeat neurological assessment shows brisk deep tendon reflexes and clonus, heightening the suspicion of imminent eclampsia. The clinical team administers a magnesium sulfate bolus in an attempt to prevent seizures, while closely monitoring for signs of magnesium toxicity, given the patient's compromised renal function evidenced by a creatinine level of 1.8 mg/dL.

With the hematology team on board, a plan is rapidly formulated to address the potential for disseminated intravascular coagulation. Fresh frozen plasma and platelet transfusions are prepared to be administered prophylactically during the surgical procedure to mitigate bleeding risks, given the patient's thrombocytopenia and elevated D-dimer levels. The anesthesiology team reviews the latest laboratory results and makes a critical decision to proceed with general anesthesia for the cesarean section, given the high risk of bleeding complications and the patient's unstable status. As the team moves swiftly to the operating room, the balance between the urgency for delivery and the stabilization of the mother becomes a primary focus, with every minute being crucial for the survival of both the mother and the fetus.

Section 4

As the operating room team swiftly transitions the patient for the emergency cesarean section under general anesthesia, a sudden change in her condition demands immediate attention. Minutes before the induction of anesthesia, the patient's heart rate spikes to 130 beats per minute, accompanied by a precipitous drop in blood pressure to 90/60 mmHg. This unexpected hemodynamic shift suggests a possible acute blood loss or an evolving cardiac event. The anesthesiology team, now faced with the dual challenge of maintaining hemodynamic stability and ensuring adequate anesthetic depth, administers rapid crystalloid infusion while preparing for potential vasopressor support.

Simultaneously, the fetal heart monitor reveals a concerning pattern of late decelerations, indicating possible fetal distress. The obstetrics team is acutely aware that the window for optimizing maternal stabilization is narrowing, with fetal oxygenation potentially compromised due to both maternal instability and the ongoing placental insufficiency. A decision is made to proceed rapidly with the cesarean section to expedite delivery and reduce the risk of further complications for both mother and child.

Post-induction, the surgical team observes unexpected oozing from the incision site, raising alarms about the effectiveness of the coagulation support provided pre-operatively. The patient's coagulation profile, updated from the stat lab results, shows an INR of 2.5 and platelet count of 50,000/mm³, suggesting a worsening coagulopathy. With the patient now under general anesthesia, the clinical teams must work in unison to deliver the baby swiftly while anticipating the need for aggressive postpartum hemorrhage management. The critical balance between surgical speed and meticulous hemostatic control underscores the complexity of managing this multifaceted case of severe preeclampsia with impending eclampsia and potential disseminated intravascular coagulation.

Section 5

As the surgical team proceeds with the cesarean section, the clinical situation evolves rapidly. Upon delivering the infant, who is immediately transferred to the neonatal team for resuscitation due to low Apgar scores of 3 at one minute and 5 at five minutes, the focus shifts back to the mother. Despite the initial rapid crystalloid infusion, the patient's hemodynamics remain precarious. Her heart rate escalates further to 145 beats per minute, and her blood pressure drops to a concerning 80/50 mmHg. These changes suggest a progression towards hypovolemic shock, possibly exacerbated by ongoing blood loss and the underlying coagulopathy.

The anesthesiology team initiates vasopressor support, administering a norepinephrine infusion to maintain perfusion and support blood pressure. Concurrently, the laboratory results reveal further deterioration: a hemoglobin level of 7.5 g/dL and an alarming drop in fibrinogen to 150 mg/dL, indicative of worsening disseminated intravascular coagulation (DIC). This necessitates an urgent transfusion protocol with packed red blood cells, fresh frozen plasma, and cryoprecipitate to address both anemia and coagulopathy. The obstetrics team, aware of the heightened risk of postpartum hemorrhage, employs uterotonics and mechanical compression techniques, including a Bakri balloon, to achieve hemostasis.

Despite these aggressive interventions, the patient's condition remains critical. Her altered level of consciousness, evidenced by a Glasgow Coma Scale score of 10, raises concerns about cerebral complications, possibly due to severe preeclampsia or intracranial hemorrhage. A head CT is considered to assess for any neurological involvement, reflecting the need for continued multidisciplinary coordination and advanced clinical judgment. This critical juncture underscores the importance of prompt, effective intervention to stabilize the patient and prevent further deterioration, as the team prepares for potential additional complications in this complex clinical scenario.